Michael G. Grey - 22 Jul 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
HZNP
Transactions as of
22 Jul 2021
Transactions value $
-$488,350
Form type
4
Filing time
23 Jul 2021, 17:00:21
Previous filing
08 Jun 2021
Next filing
20 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $11.9K +5K $2.37* 5K 22 Jul 2021 Direct
transaction HZNP Ordinary Shares Sale -$100K -1K -20% $100.00* 4K 22 Jul 2021 Direct F1
transaction HZNP Ordinary Shares Sale -$400K -4K -100% $100.05 0 22 Jul 2021 Direct F1
holding HZNP Ordinary Shares 62.3K 22 Jul 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -5K -100% $0.00* 0 22 Jul 2021 Ordinary Shares 5K $2.37 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2021.
F2 The stock option is fully vested and exercisable.